We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTMC icon
6001
Pacer Trendpilot US Mid Cap ETF
PTMC
$408M
$1.53M ﹤0.01%
44,194
+33,769
+324% +$1.17M
EGLE
6002
PUT
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$1.52M ﹤0.01%
29,400
-49,700
-63% -$3.18M
IYM icon
6003
iShares US Basic Materials ETF
IYM
$1.02B
$1.52M ﹤0.01%
12,943
-12,150
-48% -$1.68M
GFI icon
6004
PUT
Gold Fields
GFI
$37.1B
$1.52M ﹤0.01%
167,000
+56,600
+51% +$676K
AMLX icon
6005
PUT
Amylyx Pharmaceuticals
AMLX
$2.39B
$1.52M ﹤0.01%
+78,900
New +$937K
RHI icon
6006
PUT
Robert Half
RHI
$4.35B
$1.52M ﹤0.01%
20,300
+8,400
+71% +$797K
TT icon
6007
PUT
Trane Technologies
TT
$105B
$1.52M ﹤0.01%
11,700
+6,000
+105% +$830K
HYLV
6008
DELISTED
IQ S&P High Yield Low Volatility Bond ETF
HYLV
$1.52M ﹤0.01%
71,434
-208,492
-74% -$4.63M
VTWO icon
6009
PUT
Vanguard Russell 2000 ETF
VTWO
$17.5B
$1.52M ﹤0.01%
22,200
+4,400
+25% +$328K
WRK
6010
PUT
DELISTED
WestRock Company
WRK
$1.52M ﹤0.01%
38,100
-26,200
-41% -$1.23M
FOXF icon
6011
CALL
Fox Factory Holding Corp
FOXF
$864M
$1.51M ﹤0.01%
18,800
-44,000
-70% -$3.7M
PDSB icon
6012
CALL
PDS Biotechnology
PDSB
$12.3M
$1.51M ﹤0.01%
414,700
+169,600
+69% +$806K
USTB icon
6013
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.49B
$1.51M ﹤0.01%
30,924
-40,409
-57% -$1.99M
CMPS
6014
CALL
Compass Pathways
CMPS
$1.9B
$1.51M ﹤0.01%
139,800
+36,900
+36% +$372K
NTSX icon
6015
WisdomTree US Efficient Core Fund
NTSX
$1.4B
$1.51M ﹤0.01%
+45,373
New +$1.64M
SHE icon
6016
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$337M
$1.51M ﹤0.01%
19,911
+4,938
+33% +$409K
FREL icon
6017
Fidelity MSCI Real Estate Index ETF
FREL
$1.48B
$1.51M ﹤0.01%
+55,625
New +$1.66M
GNW icon
6018
Genworth Financial
GNW
$3.81B
$1.51M ﹤0.01%
427,910
+68,991
+19% +$264K
SJT
6019
San Juan Basin Royalty Trust
SJT
$131M
$1.51M ﹤0.01%
173,965
+98,992
+132% +$1.08M
IGEB icon
6020
iShares Investment Grade Systematic Bond ETF
IGEB
$1.51B
$1.51M ﹤0.01%
+33,805
New +$1.55M
SAGE
6021
DELISTED
Sage Therapeutics
SAGE
$1.51M ﹤0.01%
46,690
-59,256
-56% -$1.99M
AGR
6022
CALL
DELISTED
Avangrid, Inc.
AGR
$1.51M ﹤0.01%
32,700
+16,500
+102% +$765K
FLEX icon
6023
PUT
Flex
FLEX
$48B
$1.51M ﹤0.01%
138,141
+41,668
+43% +$516K
WH icon
6024
PUT
Wyndham Hotels & Resorts
WH
$5.41B
$1.5M ﹤0.01%
22,900
+15,600
+214% +$1.23M
GOAC
6025
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
$1.5M ﹤0.01%
150,751
-443,318
-75% -$4.41M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.